Global Creatinine Assay Market to Grow with a CAGR of 6.04% through 2028
Increasing incidence of
renal disorders impacting renal function and technological advancements in
biomedical research pertaining to kidney disorders is expected to drive the Global
Creatinine Assay Market growth in the forecast period, 2024-2028.
According to TechSci Research
report, “Global Creatinine Assay Market - Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Creatinine Assay Market stood
at USD 540.25 Million in 2022 and is anticipated to grow with a CAGR of 6.04%
in the forecast period, 2024-2028. The increasing prevalence of renal disorders, coupled with the rising
demand for creatinine measurement reagents and kits, is driven by the growing
incidence of chronic disorders that affect kidney function. These factors serve
as major drivers for the creatinine market. Additionally, the expanding
population, along with the escalating cases of renal disorders, supportive government
policies promoting renal health, and advancements in technology, contribute
significantly to the growth of the creatinine measurement market.
The demand for Creatinine
Assay Kits Market is further boosted by the need for mycobacteria detection in
urine and the increasing geriatric population suffering from renal failure.
Looking ahead, the global Creatinine Assay Kits Market is expected to be driven
by the high prevalence of chronic kidney disease (CKD) and diabetes, the
growing geriatric population, and increased research and development
initiatives. Furthermore, the introduction of exogenous marker elements,
increased government financing, and a significant number of clinical laboratory
activities are all factors that enhance the global Creatinine Assay Kits
Market.
Serum creatinine tests are
widely used in clinical chemistry laboratories worldwide. The market growth is
also fueled by favorable reimbursements and technologically innovative designs
developed by manufacturers, such as occlusive cuffs or implants connected to
pumps. However, despite these key drivers, there are a few restraints that may
impact the growth of this market.
The high prevalence of renal
disorders globally is a major factor driving market growth. According to
estimates from the American Kidney Fund, kidney disorders were the ninth
leading cause of death in the U.S. It is estimated that more than 1 in 7 US adults,
approximately 35.5 million people or 14%, will suffer from Chronic Kidney
Disease (CKD) by 2023. Moreover, according to the Global Burden of Disease
(GBD) estimates, there were around 1.2 million deaths due to cardiovascular
disorders in 2015, with cardiovascular disorders being stimulated by reduced
glomerular filtration rate. This high prevalence has prompted companies and
health organizations to invest in the development of robust tools for measuring
renal disorders.
The demand for creatinine
measurement kits and reagents is also supported by the increasing incidence of
other chronic disorders that affect kidney function. For example, diabetes and
high blood pressure account for almost 44% and 29% of total kidney failure
cases, respectively. Market growth is further boosted by the growing global
geriatric population, which is more prone to renal disorders, supportive
government regulations promoting renal health, and the introduction of
monitoring technologies. One promising technological advancement includes the
use of point-of-care creatinine measuring devices, which provide a rapid method
and eliminate the need for skilled analytical personnel to perform complex
monitoring techniques.
Furthermore, to enhance
market growth, the National Kidney Disease Education Program's laboratory
working group collaborated with the European Federation of Clinical Chemistry,
Laboratory Medicine & International Federation of Clinical Chemistry and Laboratory
Medicine (IFCC) to establish the Creatinine Standardization Program. This
government initiative has reduced interlaboratory variation in creatinine assay
calibration, resulting in improved accuracy of glomerular filtration rate
estimation. Such initiatives assist healthcare professionals in detecting and
treating various renal diseases, thereby improving patient outcomes. On the
other hand, healthcare professionals are shifting their preferences towards
novel techniques, including the identification of renal dysfunction biomarkers,
while the lack of predictive value remains a hindrance to the growth of the
creatinine measurement market.
Browse over 26 market
data Figures spread through 91 Pages and an in-depth TOC on "Global
Creatinine Assay Market”
The Global Creatinine Assay Market
is segmented into test type, product, sample, end user, regional distribution, and
company.
Based
on test type, Jaffe Kinetic Method is expected to dominate the global
creatinine assay market. The Jaffe reaction is a colorimetric method widely
utilized in clinical chemistry for measuring creatinine levels in blood and
urine using Jaffe's Kinetic Test Kits. According to the National Kidney
Foundation, approximately 10% of the global population is affected by chronic
kidney disease (CKD), leading to millions of deaths annually.
The
Jaffe's Kinetic Test Kits segment holds a significant market share in the
creatinine assay kits market and is projected to maintain a similar trend
throughout the forecast period. This can be attributed to its status as the
conventional method for creatinine measurement, wide availability of products,
and cost-effectiveness of these kits. The rising incidence of renal disorders
and other chronic conditions impacting renal function, coupled with
technological advancements in biomedical research related to kidney disorders,
are key driving factors in the growth of the Jaffe's kinetic test kits segment.
Based
on end user, the market can be categorized into hospitals and diagnostic
laboratories. Among these, the hospital segment is projected to capture the
largest market share during the forecast period, as hospitals cater to a larger
patient base. Moreover, hospitals have greater financial resources, enabling
them to utilize more advanced kits and reagents, ultimately yielding more
accurate results in creatinine tests. Conversely,
diagnostic laboratories are anticipated to exhibit the highest growth rate
during the forecast period.
Major companies
operating in Global Creatinine Assay Market are:
- Abbott Laboratories
- Thermo Fisher Scientific
- Merck KGaA
- Quidel Corporation
- Cell Biolabs, Inc.
- Genway Biotech
- Randox Laboratories Ltd.
- ACON Laboratories
- Nova Biomedical
- Sysmex India Pvt. Ltd.
Download Free Sample Report
Customers can also request for 10% free customization on
this report.
“The rising prevalence of renal and other chronic
disorders, technological advancements in biomedical research related to kidney
disorders, and increased research and development efforts are the primary
driving factors in the creatinine assay kits market. Creatinine assay kits are
used to measure creatinine levels in serum/plasma, urine, and other biological
samples. The creatinine assay helps analyze protein metabolism in the body,
with creatinine levels being influenced by factors such as changes in muscle
mass, pregnancy, and cancer. Elevated creatinine levels in blood tests indicate
poor kidney function. Specific creatinine assay kits are used to perform the
creatinine test for various conditions like hypertension, diabetes, and
cancers.
Market growth in this sector is primarily propelled by the
growing incidence of renal disorders, the impact of other chronic disorders on
renal function, increased awareness and adoption of preventive healthcare
practices, favorable government initiatives promoting renal health, rapid
growth in the elderly population, and advancements in biomedical research on
kidney disorders. However, the limited utilization of creatinine assay kits in
in vitro diagnostics (IVD) and the identification of novel biomarkers for renal
dysfunction may pose challenges to market growth in the future.,” said Mr.
Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“Global
Creatinine Assay Market By Test Type (Jaffe Kinetic
Method, Enzymatic Method), By Product (Reagents, Kits), By Sample (Blood/Serum,
Urine), By End User (Hospitals, Diagnostic Laboratories), By Region, By
Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future
growth potential of Global Creatinine Assay Market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Creatinine Assay Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web: https://www.techsciresearch.com